| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.15 | 0.004 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.097 | 0.004 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.004 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.15 | 0.004 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | 0.13 | 0.005 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.083 | 0.005 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.005 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |